Molecular Partners AG(MOLN) - 2022 Q4 - Annual Report

EXHIBIT 99.1 Molecular Partners Reports Corporate Highlights From Q4 2022 and Key Financials for Full Year 2022 Research & Development Highlights: Leadership & Governance: Financial: 2023 Outlook: ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., March 09, 2023 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR: Molecular Partners AG (SIX: MOLN, NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built proteins known as DARPin therapeutics, today announced its corpor ...